Abstract

LASPRILLA-TOVAR, Juan David et al. Bone Health in Patients with Duchenne Muscular Dystrophy. Rev. Cienc. Salud [online]. 2025, vol.23, n.spe, e23e9.  Epub Apr 22, 2025. ISSN 1692-7273.  https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.13614.

Patients with Duchenne muscular dystrophy are treated with glucocorticoids aiming to modify the natural history of the disease. However, their prolonged use is associated with growth disturbances, alterations in skeletal development and increased fracture rates. Additionally, patients with Duchenne muscular dystrophy have increased bone fragility with changes in bone mass that may or may not be the result of glucocorticoid use. This fragility increases the risk of fractures, thus necessitating proper diagnosis, follow-up, and treatment of these patients. This review describes how to adequately assess and manage bone health in patients with DMD.

Keywords : Duchenne muscular dystrophy; bone; health.

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )